KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Shares Issued (2016 - 2025)

Historic Shares Issued for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to $2.4 million.

  • Xenon Pharmaceuticals' Shares Issued changed N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 9516.67%. This contributed to the annual value of $12.1 million for FY2024, which is 9658.18% down from last year.
  • Xenon Pharmaceuticals' Shares Issued amounted to $2.4 million in Q3 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Shares Issued registered a high of $324.0 million during Q4 2023, and its lowest value of $15000.0 during Q4 2021.
  • Its 5-year average for Shares Issued is $56.8 million, with a median of $1.2 million in 2025.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Shares Issued surged by 184701333.33% in 2022 and then tumbled by 9627.04% in 2024.
  • Over the past 5 years, Xenon Pharmaceuticals' Shares Issued (Quarter) stood at $15000.0 in 2021, then soared by 1847013.33% to $277.1 million in 2022, then rose by 16.93% to $324.0 million in 2023, then tumbled by 96.27% to $12.1 million in 2024, then plummeted by 80.47% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $65000.0 for Q2 2025, and $1.2 million during Q1 2025.